APA (7th ed.) Citation

Zeng, X., Wang, L., Wang, M., Hu, Z., Li, X., Fei, G., . . . Yang, Z. (2025). BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo. Pharmaceuticals (14248247), 18(2), 201. https://doi.org/10.3390/ph18020201

Chicago Style (17th ed.) Citation

Zeng, Xin-Xin, Liang Wang, Ming-Yu Wang, Zhen-Ran Hu, Xiang-Ke Li, Guo-Jun Fei, Ling Ling, Yu-Ting Fan, and Ze-Min Yang. "BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo." Pharmaceuticals (14248247) 18, no. 2 (2025): 201. https://doi.org/10.3390/ph18020201.

MLA (9th ed.) Citation

Zeng, Xin-Xin, et al. "BuZhong YiQi Formula Alleviates Postprandial Hyperglycemia in T2DM Rats by Inhibiting α-Amylase and α-Glucosidase In Vitro and In Vivo." Pharmaceuticals (14248247), vol. 18, no. 2, 2025, p. 201, https://doi.org/10.3390/ph18020201.